# A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults

> **NCT07395024** · PHASE1 · RECRUITING · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 54 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Setidegrasib
- **DRUG:** Fluconazole
- **DRUG:** Carbamazepine
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT07395024
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-03
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395024, "A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07395024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*